.Merck defeats revenues assumptions, brings up purchases overview on strong need for top drugs like Keytruda CNBCMerck & Co. (MRK US) Beats Profit Projections as Keytruda Sales Rise BloombergMerck Inventory: Pharma Titan Posts Solid End Results, Yet Expectation Drops Short Financier's Organization DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck defeats income as well as purchases requirements amid Keytruda asset, yet offers combined full-year overview MarketWatch.